In light of the ‘test and treat’ strategy in Kenya, initiation of ART is no longer based on CD4 count but it is important to know the RIs as this may influence prognosis and treatment response and is used to determine the timing of co-infection prophylaxis initiation. The gene discussed is CD4; the disease is coinfection.